骨髓增生异常综合征贫血的新疗法 - Suppr

Suppr

超能文献

New Approaches for Anemia in MDS.

作者信息

Platzbecker Uwe

机构信息

University of Leipzig, Medical Clinic I, Hematology and Cellular Therapy, Liebigstr. 22, 04103 Leipzig, Germany.

出版信息

Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S59-S60. doi: 10.1016/S2152-2650(20)30463-8.

DOI:10.1016/S2152-2650(20)30463-8

PMID:32862871

Abstract

摘要

相似文献

New Approaches for Anemia in MDS.

Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S59-S60. doi: 10.1016/S2152-2650(20)30463-8.

New drugs for myeloid neoplasms with ring sideroblasts: Luspatercept vs imetelstat.

Am J Hematol. 2021 Jul 1;96(7):761-763. doi: 10.1002/ajh.26197. Epub 2021 May 3.

Luspatercept in Myelodysplastic Syndromes: Who and When?

Hematol Oncol Clin North Am. 2020 Apr;34(2):393-400. doi: 10.1016/j.hoc.2019.10.004. Epub 2020 Jan 21.

Luspatercept: First Approval.

Drugs. 2020 Jan;80(1):85-90. doi: 10.1007/s40265-019-01251-5.

Myelo-deception: Luspatercept & TGF-Beta ligand traps in myeloid diseases & anemia.

Leuk Res. 2020 Oct;97:106430. doi: 10.1016/j.leukres.2020.106430. Epub 2020 Jul 30.

The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.

Ann Hematol. 2020 Jan;99(1):7-19. doi: 10.1007/s00277-019-03799-4. Epub 2019 Oct 25.

Novel therapies in low- and high-risk myelodysplastic syndrome.

Expert Rev Hematol. 2019 Oct;12(10):893-908. doi: 10.1080/17474086.2019.1647778. Epub 2019 Jul 31.

Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia.

Drugs. 2021 Jun;81(8):945-952. doi: 10.1007/s40265-021-01527-9. Epub 2021 May 10.

Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes.

J Clin Invest. 2020 Feb 3;130(2):582-589. doi: 10.1172/JCI133678.

Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial.

Blood. 2022 Jan 27;139(4):624-629. doi: 10.1182/blood.2021012589.

引用本文的文献

Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.

Cancers (Basel). 2025 May 7;17(9):1587. doi: 10.3390/cancers17091587.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

New Approaches for Anemia in MDS.

Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S59-S60. doi: 10.1016/S2152-2650(20)30463-8.

New drugs for myeloid neoplasms with ring sideroblasts: Luspatercept vs imetelstat.

Am J Hematol. 2021 Jul 1;96(7):761-763. doi: 10.1002/ajh.26197. Epub 2021 May 3.

Luspatercept in Myelodysplastic Syndromes: Who and When?

Hematol Oncol Clin North Am. 2020 Apr;34(2):393-400. doi: 10.1016/j.hoc.2019.10.004. Epub 2020 Jan 21.

Luspatercept: First Approval.

Drugs. 2020 Jan;80(1):85-90. doi: 10.1007/s40265-019-01251-5.

Myelo-deception: Luspatercept & TGF-Beta ligand traps in myeloid diseases & anemia.

Leuk Res. 2020 Oct;97:106430. doi: 10.1016/j.leukres.2020.106430. Epub 2020 Jul 30.

The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.

Ann Hematol. 2020 Jan;99(1):7-19. doi: 10.1007/s00277-019-03799-4. Epub 2019 Oct 25.

Novel therapies in low- and high-risk myelodysplastic syndrome.

Expert Rev Hematol. 2019 Oct;12(10):893-908. doi: 10.1080/17474086.2019.1647778. Epub 2019 Jul 31.

Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia.

Drugs. 2021 Jun;81(8):945-952. doi: 10.1007/s40265-021-01527-9. Epub 2021 May 10.

Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes.

J Clin Invest. 2020 Feb 3;130(2):582-589. doi: 10.1172/JCI133678.

Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial.

Blood. 2022 Jan 27;139(4):624-629. doi: 10.1182/blood.2021012589.

引用本文的文献

Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.

Cancers (Basel). 2025 May 7;17(9):1587. doi: 10.3390/cancers17091587.